Al's Comment:
There is a drug in clinical trials that targets this marker in other cancers. This project will do preclinical testing which, if successful, will lead to a clinical trial of this drug in pediatric DIPG.
Posted on: 01/30/2019
Musella Foundation awards a pediatric brain tumor grant!
Hewlett, NY 1/309/2019 - The Musella Foundation announced that it has awarded a $30,000 grant to Dr. Bandopadhayay and Dr. Ligon at Dana-Farber Cancer Institute for the project: "MDM2 as a therapeutic target in PPM1D mutant Diffuse Intrinsic Pontine Glioma" This grant is from our DIPG All-In-Initiative fund.
About the Musella Foundation
The Musella Foundation For Brain Tumor Research & Information, Inc is a 501(c)3 non- profit organization dedicated to speeding up the search for the cure of brain tumors, as well as helping families deal with the diagnosis of brain cancer, by funding innovative brain tumor research, education, advocacy, emotional and financial support for families that are dealing with brain tumors and organizing the brain tumor community to work together as an army to fight the disease.
Contact: Al Musella, DPM
President Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740
musella@virtualtrials.com
Click HERE to return to brain tumor news headlines.
